Internal bleeding

Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India

Retrieved on: 
Friday, March 22, 2024
Cardiac output, U.S. FDA, Internal bleeding, Partnership, System, Patient, Research, Trauma, Diarrhea, Hypovolemic shock, Mortality, Gastrointestinal bleeding, Manuscript, Laboratory, Blood volume, Standard of care, DRUGS, Clinical trial, Resuscitation, Safety, DCGI, Phase, Vomiting, Blood, FDA, Food, Shock (mechanics), Emerging market, Generic drug

Developed by Pharmazz for potential global use, Centhaquine is a resuscitative agent presently indicated for treating hypovolemic shock by Drugs Controller General of India (DCGI).

Key Points: 
  • Developed by Pharmazz for potential global use, Centhaquine is a resuscitative agent presently indicated for treating hypovolemic shock by Drugs Controller General of India (DCGI).
  • As per the agreement, Dr. Reddy's has received exclusive rights to market and distribute Centhaquine in India.
  • For patients with hypovolemic shock, I believe Dr. Reddy's is the best partner for Pharmazz to market Centhaquine, an innovative, first-in-class novel resuscitative agent, in India."
  • U.S. FDA clearance of our Phase III IND is an important milestone for Pharmazz and the potential future treatment of hypovolemic shock patients.

More hysterectomies can be averted with earlier uterine artery embolization for postpartum hemorrhage

Retrieved on: 
Saturday, March 23, 2024
Health, Postpartum bleeding, Hysterectomy, Uterus, Internal bleeding, Uterine artery embolization, Incidence, Abdominal pain, Patient, Uncontrolled, Research, Bleeding, University, Society, Artery, Woman, Treatment, Blood, Birth control

FAIRFAX, Va., March 23, 2024 /PRNewswire/ -- Early intervention with a minimally invasive treatment called uterine artery embolization (UAE) can help women avoid hysterectomy due to severe bleeding after childbirth, according to a new study being presented at the Society of Interventional Radiology Annual Scientific Meeting in Salt Lake City.

Key Points: 
  • The study was a retrospective review of 66 patients (median age, 31) who underwent UAE for uncontrolled postpartum hemorrhage at a single, high-volume medical center between 2014 and 2022.
  • Postpartum hemorrhage is a rare but potentially deadly complication of childbirth.
  • The study found that it was more likely to occur in patients who experienced greater blood loss before embolization.
  • Abstract #189 : Short-Term and Long-Term Outcomes of Uterine Artery Embolization for Treatment of Uncontrolled Post-Partum Hemorrhage.

For Mama Campaign Launches Fundraising Effort to End Today's Urgent - and Solvable - Maternal Mortality Crisis

Retrieved on: 
Tuesday, March 12, 2024
Mother, Health, Organization, La mamma (song), Internal bleeding, Bill, Muslims, Child, Communication, Death, Pregnancy, Woman, Investment, AlMaghrib Institute, USD, Mama, Birth control

LONDON, March 12, 2024 /PRNewswire/ -- Under the For Mama campaign, a coalition of 20+ charitable organizations and faith-based philanthropies have launched a fundraising effort to protect mothers and babies from preventable deaths. Anyone can donate by visiting actformama.org to provide mothers and babies with the care, tools, and resources they need to survive and thrive.

Key Points: 
  • 'For Mama' is the first-of-its-kind campaign mobilizing the Muslim community to support mothers' and babies' health.
  • In response, For Mama partners have rallied together this Ramadan to encourage greater investments in maternal and newborn health.
  • "'For Mama' is the first-of-its-kind campaign mobilizing the Muslim community to advocate and prioritize giving to mothers' and babies' health.
  • Donations made to For Mama will support maternal and newborn health programs across North America, the United Kingdom and globally.

For Mama Campaign Launches Fundraising Effort to End Today's Urgent - and Solvable - Maternal Mortality Crisis

Retrieved on: 
Tuesday, March 12, 2024
Mother, Health, Organization, La mamma (song), Internal bleeding, Bill, Muslims, Child, Communication, Death, Pregnancy, Woman, Investment, AlMaghrib Institute, USD, Mama, Birth control

LONDON, March 12, 2024 /PRNewswire/ -- Under the For Mama campaign, a coalition of 20+ charitable organizations and faith-based philanthropies have launched a fundraising effort to protect mothers and babies from preventable deaths. Anyone can donate by visiting actformama.org to provide mothers and babies with the care, tools, and resources they need to survive and thrive.

Key Points: 
  • LONDON, March 12, 2024 /PRNewswire/ -- Under the For Mama campaign, a coalition of 20+ charitable organizations and faith-based philanthropies have launched a fundraising effort to protect mothers and babies from preventable deaths.
  • In response, For Mama partners have rallied together this Ramadan to encourage greater investments in maternal and newborn health.
  • "'For Mama' is the first-of-its-kind campaign mobilizing the Muslim community to advocate and prioritize giving to mothers' and babies' health.
  • Donations made to For Mama will support maternal and newborn health programs across North America, the United Kingdom and globally.

Evidence review: Maternal mental conditions drive climbing death rate in U.S.

Retrieved on: 
Wednesday, February 21, 2024
Mental health, Woman, PNP, Suicide, Infection, Prenatal development, Hospital, Public health, Bleeding, MPA, Fatality, Maternal death, Mental, DSM-IV codes, Pregnancy, Communication, Death, Internal bleeding, Risk, Health, JAMA Psychiatry, FACOG, University, Infant, Disease, Mother, White, Health policy, Maternal health, Child, Mortality, Drug overdose, George Washington University, Research, Medicine, Depression

“The contribution of mental health conditions to the maternal morbidity and mortality crisis that we have in America is not widely recognized,” said Katherine L. Wisner, M.D.

Key Points: 
  • “The contribution of mental health conditions to the maternal morbidity and mortality crisis that we have in America is not widely recognized,” said Katherine L. Wisner, M.D.
  • , associate chief of Perinatal Mental Health and member of the Center for Prenatal, Neonatal & Maternal Health Research at Children’s National.
  • Overdose and other maternal mental health conditions are taking the lives of more than twice as many women as postpartum hemorrhage, the second leading cause of maternal death.
  • Mental health conditions such as suicide or opioid overdose are to blame for nearly 23% of maternal deaths in America, according to reports from three dozen Maternal Morbidity and Mortality Review Committees, which are state-based organizations that review each maternal death within a year of pregnancy.

ISMP Announces Three Additions to 2024-2025 Targeted Medication Safety Best Practices for Hospitals

Retrieved on: 
Thursday, February 22, 2024
Best practice, Member, Collection, Hospital, PSO, Tranexamic acid, Confusion, Vaccine, Risk, Internal bleeding, Safety, Health, Health care, Best, Reconciliation (United States Congress), Glass, Pharmacist, Organization, Patient, Patient safety organization, Sibling, Mortality, Anesthetic, Failure

PLYMOUTH MEETING, Pa., Feb. 22, 2024 /PRNewswire/ -- Healthcare organizations deciding on where to focus their medication safety efforts over the next two years now have updated recommendations from the Institute for Safe Medication Practices (ISMP). ISMP has released its 2024-2025 Targeted Medication Safety Best Practices for Hospitals to identify recurring problems that continue to cause fatal and harmful errors despite repeated warnings and mobilize widespread national action to prevent them.

Key Points: 
  • ISMP has released its 2024-2025 Targeted Medication Safety Best Practices for Hospitals to identify recurring problems that continue to cause fatal and harmful errors despite repeated warnings and mobilize widespread national action to prevent them.
  • ISMP's Best Practices help hospitals and health systems decide where to focus their medication safety efforts.
  • This year's list includes new Best Practices on preventing wrong-route errors with tranexamic acid, errors at transitions in care, and mistakes with vaccines in inpatient and outpatient settings.
  • "ISMP encourages hospitals and health systems to review this latest set of Best Practices and make implementation a priority," says Christina Michalek, BS, RPh, FASHP, Director of Membership and Patient Safety Organization (PSO).

Vivacelle Bio Integrates Sub-Saharan Africa Strategy into Series B Financing Round

Retrieved on: 
Thursday, February 22, 2024
Blood pressure, Blood, School, Sepsis, Woman, IIA, Bleeding, Doctor of Philosophy, Resuscitation, The, Shock, MD, Diarrhea, Temperature, Septic, University, Nitric oxide, Shock (mechanics), Senior advisor, Finger, Life, Urinary tract infection, Risk, Internal bleeding, Pelvic floor dysfunction, Malaria, Hypovolemia, Nanoparticle, Gangrene, Neonatal sepsis, JD, Patient, Septic shock, Clinical trial, UMKC, Child, Reperfusion injury, Hypotension, Partnership

Targeted $20M Series B Round to include Sub-Saharan Africa in product development.

Key Points: 
  • Targeted $20M Series B Round to include Sub-Saharan Africa in product development.
  • Vivacelle Bio is partnering with Propelevate to drive the Sub-Saharan Africa strategy, which is fully integrated into its Series B financing round.
  • Through partnership with Propelevate, Vivacelle Bio will engage global health funders and stakeholders during final stages of product development, and Propelevate will drive Vivacelle Bio's go-to-market strategy for African markets upon regulatory approval.
  • "We are excited to partner with Vivacelle Bio because of their commitment to Sub-Saharan Africa.

Legal-Bay Dedicates New Web Page Focusing on Cases Involving Pedestrian Accidents

Retrieved on: 
Thursday, February 15, 2024
Brain damage, Social media, Weather, Lawsuit, Internal bleeding, Pain, Injury, Distracted driving, Head Injuries, Risk, Back pain, Amputation, Judgement, Personal injury, Tetraplegia, Trauma, Fracture, Accident, Failure, Pedestrian, Insurance

NEWARK, N.J., Feb. 15, 2024 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Pre-Settlement Funding Company, announced today that they are focusing more heavily on cases involving pedestrian accidents. These cases include any kind of pedestrian incident resulting in personal injury due to no fault of their own. Some of the cases Legal-Bay will evaluate for pre-settlement funding, settlement loan, or a settlement cash advance involve: fractures, intersection accidents, distracted driving, speeding, crosswalk accidents, bus accidents, hit and runs, bike accidents, fractures, traumatic brain injuries, cases involving internal injuries or spinal injuries, negligence, weather conditions, involvement or impairment due to alcohol and drugs, amputation, back pain, wrongful death, drunk driving, failure to yield, cases involving soft tissue injury or crush injuries, cuts and bruises, slipped discs from accident, pedestrians struck while stepping onto crosswalk, head injuries, or incidents involving drivers that disobey traffic signs or signals.

Key Points: 
  • NEWARK, N.J., Feb. 15, 2024 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Pre-Settlement Funding Company, announced today that they are focusing more heavily on cases involving pedestrian accidents.
  • These cases include any kind of pedestrian incident resulting in personal injury due to no fault of their own.
  • However, even cases not listed above are eligible for a free case evaluation, as Legal-Bay has extensive experience with all types of pedestrian accident cases.
  • This includes any incident involving personal injury, negligence, or misconduct when it comes to obeying pedestrian rules, rights, and laws.

Medicines360 and DKT WomanCare Announce Strategic Partnership to Expand Access to the Hormonal IUD Avibela™

Retrieved on: 
Wednesday, January 31, 2024
SAN, Nausea, Clinical trial, Perforation, Birth, Fibroid, Internal bleeding, Liver failure, Infection, Artery, Pelvic pain, DKT International, Jaundice, Anticoagulant, Blood pressure, Ovarian cyst, Woman, Acne, Organization, Partnership, Endometritis, Angioedema, History, Abscess, Contraindication, DKT, Peritonitis, Rash, Coagulopathy, Dyspareunia, Inflammatory cytokine, Adhesion, Vomiting, Bacterial vaginosis, Headache, Bowel obstruction, IUS, Uterus, STI, Breast cancer, Miscarriage, Patient, Fertility, Sepsis, Marketing, Risk, Stroke, Organ, Streptococcus, Hormone-sensitive cancer, Liver tumor, Cyst, Intrauterine device, GAS, Pregnancy, PID, Social marketing, Vaginitis, Migraine, Myocardial infarction, Health, Brain, Birth control

"As a global nonprofit pharmaceutical organization dedicated to expanding access to affordable reproductive health products for women, DKT WomanCare is an ideal partner for our organization," said Dr. Andrea Olariu, CEO of Medicines360.

Key Points: 
  • "As a global nonprofit pharmaceutical organization dedicated to expanding access to affordable reproductive health products for women, DKT WomanCare is an ideal partner for our organization," said Dr. Andrea Olariu, CEO of Medicines360.
  • “DKT WomanCare looks forward to leveraging our global partnerships and commercial relationships to ensure every woman, regardless of income, can access affordable, high-quality contraception.
  • As the supplier of AVIBELA, Medicines360 will focus on providing quality assurance and regulatory oversight, as well as ensuring sustainable product supply to DKT WomanCare and global procurement agencies.
  • Together, Medicines360 and DKT WomanCare will meet the growing demand for quality-assured, affordable hormonal IUDs and help build a robust and sustainable global contraceptive market.

Preeclampsia Foundation Announces New 2024 Leadership of Board of Directors

Retrieved on: 
Monday, January 29, 2024
CTP, Pre-eclampsia, RNC, MMM, JD, Organization, MPH, Communication, Mother, Women's health, Master, Senate, DeBevoise, Medical director, Martha Plimpton, ISG Business School, MPPA, Mortality, AWHONN, MBA, CFP, Marketing, Security (finance), Justice, Certified Treasury Professional, Internal bleeding, Certified Public Accountant, Nursing credentials and certifications, APN, CPE, Merck, Management

MELBOURNE, Fla., Jan. 29, 2024 /PRNewswire/ -- The Preeclampsia Foundation welcomed a new group of officers to their 2024 Board of Directors today.

Key Points: 
  • MELBOURNE, Fla., Jan. 29, 2024 /PRNewswire/ -- The Preeclampsia Foundation welcomed a new group of officers to their 2024 Board of Directors today.
  • "We continue to be honored and grateful for the professional leadership provided by the officers and members of our Board of Directors," said Preeclampsia Foundation CEO Eleni Tsigas.
  • Treasurer Raphaël Charbit joined the Preeclampsia Foundation board of directors in 2023, bringing his vast financial management expertise to the team.
  • The Foundation also expresses its deep gratitude to immediate past chair, Dr. Rakhi Dimino, for her leadership and guidance on the Board of Directors.